CONTESTABILE, ANTONIO
CONTESTABILE, ANTONIO
ARAG - AREA FINANZA E CONTABILITÀ
Personale esterno ed autonomi
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
2016 Peña-Altamira, E; Prati, F; Massenzio, F; Virgili, M; Contestabile, A; Bolognesi, Ml; Monti, B.
Zinc supplementation in rats impairs hippocampal-dependent memory consolidation and dampens post-traumatic recollection of stressful event.
2016 Contestabile, A; Peña-Altamira, E; Virgili, M; Monti, B.
Chronic valproic acid administration impairs contextual memory and dysregulates hippocampal GSK-3β in rats.
2013 Sintoni S; Kurtys E; Scandaglia M; Contestabile A; Monti B.
Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis
2012 Contestabile A.; Sintoni S.; Monti B.
Neuronal-glial Interactions Define the Role of Nitric Oxide in Neural Functional Processes
2012 Contestabile A; Monti B; Polazzi E.
Valproic acid neuroprotection in 6-OHDAlesioned rat, a model for parkinson's disease
2012 Monti B.; Mercatelli D.; Contestabile A.
Nitric oxide control of MYCN expression and multi drug resistance genes in tumours of neural origin.
2010 Porro A.; Chrochemore C.; Cambuli F.; Iraci N.; Contestabile A.; Perini G.
Nitric oxide control of proliferation in nerve cells and in tumor cells of nervous origin.
2010 E. Pena-Altamira; P. Petazzi; A. Contestabile
Targeing nitric oxide for tumor therapy.
2010 A. Contestabile
Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease?
2010 A. D'Arrigo; D. Colavito; E. Pena-Altamira; M. Fabris; M. Dam; A. Contestabile; A. Leon
Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha synuclein
2010 Monti B.; Gatta V.; Piretti F.; Raffaelli S.; Virgili M.; Contestabile A.
Benefits of caloric restriction on brain aging and related pathological states: understanding mechanisms to devise novel therapies.
2009 Contestabile A
Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection
2009 Monti B.; Polazzi E.; Contestabile A.
Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity
2009 Eleuteri S.; Monti B.; Brignani S.; Contestabile A.
Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model froamyotrophic lateral sclerosis
2009 Crochemore C.; Virgili M.; Bonamassa B.; Canistro D.; Pena-Altamira E.; Paolini M.; Contestabile A.
Memory-enhancing drugs: a molecular perspective
2009 Monti B.; Contestabile A.
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta2
2009 Polazzi, E.; Pena Altamira, L. E.; Eleuteri, S. C.; Barbaro, M. R.; Casadio, C.; Contestabile, A.; Monti, B.
Neuroprotection of microglia conditioned media from apoptotic death induced by staurosporine and glutamate in cultures of rat cerebellar granule cells.
2008 Eleuteri S.; Polazzi E.; Contestabile A.
Regulation of transcription factors by nitric oxide in neurons and in neural-derived tumor cells
2008 Contestabile A.
The place of choline acetyltransferase activity measurement in the "cholinergic hypothesis" of neurodegenerative diseases
2008 Contestabile A.; Ciani E.; Contestabile A.